T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and ...

AbbVie has filed for U.S. Food and Drug Administration approval of its investigational pivekimab sunirine antibody-drug conjugate for the treatment of the rare blood cancer blastic plasmacytoid ...

AbbVie (NYSE: ABBV) today announced submission of a new Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of investigational Pivekimab sunirine (PVEK) for ...

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) announced that the U.S. Food ...

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) announced that the U.S. Food and Drug Administration (FDA) has approved its first-in-human Investigational New ...

During a live event, Taha Al-Juhaishi, MD, discussed long-term outcomes of treating blastic plasmacytoid dendritic cell neoplasm and how to navigate toxicities and transplant.

This trial reveals that carrot-derived rhamnogalacturonan-I boosts Bifidobacteria and supports immune function, highlighting ...

With two late-stage programs set to read out in the next 48 months, Biogen is translating its wealth of experience in multiple sclerosis to lupus—developing a pipeline BMO Capital Markets analysts ...

The maternal–fetal interface is the meeting point for maternal and fetal cells during pregnancy. It's long been understood as an area of conflict, where the placenta—a fetal organ—invades the mother ...

Spaceflight makes certain human stem cells age faster, a new study has found, furthering scientists’ understanding of the potential effects of space exploration on the human body. Stem cells are found ...

After just 32 days of spaceflight, stem cells that play a vital role in blood and immune system health showed signs of accelerated aging. reading time 3 minutes Spaceflight pushes the human body to ...